Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Revolution Medicines, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
Prev close 205.08 · gapped below the open, then crossed back over prior close. High/low 206.80 at 6:45 am ET, 200.72 at 11:30 am ET.
695 institutional managers report a position in Revolution Medicines, Inc. worth $41.1B between them, filed on form 13F for the quarter ending 2026-06-30. 42 of them hold 80% of it, the largest being BlackRock, Inc. at 6.25%.
670 more managers in the register
42 managers hold 80% of the $41.1B institutional base. The other 653 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Farallon Capital Management LLC, Paradigm Biocapital Advisors LP, Jupiter Topco LLC +14 more · 6.18% of RVMD, 5.73% of TNGX
via Baker Bros. Advisors LP, Jupiter Topco LLC, Wellington Management Group LLP +11 more · 5.22% of RVMD, 8.92% of MDGL
via Baker Bros. Advisors LP, Jupiter Topco LLC, Deerfield Management Co +12 more · 5.22% of RVMD, 5.05% of PRAX
via Farallon Capital Management LLC, Jupiter Topco LLC, Baker Bros. Advisors LP +7 more · 6.18% of RVMD, 7.27% of CRNX
via Jupiter Topco LLC, Baker Bros. Advisors LP, Wellington Management Group LLP +9 more · 4.90% of RVMD, 7.64% of GPCR
via Jupiter Topco LLC, Nextech Invest, Ltd., Paradigm Biocapital Advisors LP +6 more · 4.90% of RVMD, 6.24% of TYRA
Managers holding a meaningful stake in RVMD also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
RVMD (Revolution Medicines, Inc.) has 7 disclosed suppliers and 2 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: SNY −0.05%, in industrials & materials.